VRXA Veraxa Biotech AG
Company Analysis
Latest News
π΄ Veraxa Biotech is trading 5% down; no clear catalyst identified
Veraxa Biotech is trading lower at $1.24, down 5.34%, on September 30, 2026, with no clear company-specific catalyst identified. - The event calendar lists a...
π΄ Veraxa Biotech is trading 5% down with no clear catalyst identified
Veraxa Biotech is trading 5.1% lower at $1.30 on September 29, 2026, with no clear company-specific catalyst identified. - Shares closed at $1.37 on September...
π’ Veraxa Biotech is trading 6.38% up in pre-market amid broader biotech strength
Veraxa Biotech is trading 6.38% higher at $1.50 in pre-market following broader biotechnology strength; no company-specific catalyst was identified. - Shares...
π’ Veraxa Biotech is trading 6.5% up in pre-market amid broader biotech momentum
Veraxa Biotech is trading 6.5% up in pre-market at $1.48, versus the September 23 close of $1.39, amid broader biotech momentum on September 24, 2026. - XBI...
π’ Veraxa Biotech is trading 11.35% up in pre-market on biotech-sector strength
Veraxa Biotech is trading at $1.57, up 11.35%, with biotech-sector strength providing the strongest explanation. - No fresh company-specific announcement or...
π’ Veraxa Biotech is trading 5.63% up in pre-market β no fresh catalyst identified
Veraxa Biotech is trading 5.63% up at $1.50 after rising from the September 21 close of $1.42; no fresh company-specific catalyst dated September 22, 2026 was...
π’ Veraxa Biotech is trading 7.89% up in pre-market with no clear catalyst identified
Veraxa Biotech is trading 7.89% up at $1.64 in pre-market; no new company-specific announcement was identified for September 16, 2026, and the immediate reason...
π΄ Veraxa Biotech is trading 5.52% down today amid biotech-sector pressure after disappointing drug-trial news elsewhere
Veraxa Biotech is trading 5.52% down at $1.54, with biotechnology weakness and broad risk-off conditions the most likely immediate drivers. - No...
π’ Veraxa Biotech is trading 5.65% up today; catalyst remains unclear
Veraxa Biotech is trading 5.65% up at $1.68, though the catalyst remains unclear. - No clear company-specific announcement dated September 10, 2026, was...
π΄ Veraxa Biotech is trading 10.23% down today after likely profit-taking
Veraxa Biotech is trading at $1.58, down 10.23%, as likely profit-taking follows its sharp multi-session advance. - Shares rose 15.03% to $1.76 on September 4...
π΄ Veraxa Biotech is trading 6.25% down today amid likely profit-taking
Veraxa Biotech is trading 6.25% down at $1.65, pressured by softer broader-market sentiment and likely profit-taking after a sharp multi-session rally. -...
π΄ Veraxa Biotech is trading 5.9% down in pre-market following a sharp rally during prior sessions
Veraxa Biotech is trading at $1.66 (-5.93%) after a sharp rally during prior sessions. - The stock declined from the $1.76 September 7 close. - No new...
π’ Veraxa Biotech is trading 13.07% up today after appointing Raju Willener as CFO
Veraxa Biotech is trading 13.07% up at $1.73 after appointing Raju Willener as chief financial officer, effective September 4, 2026. - He succeeds Carl von...
Veraxa Biotech Swaps CFOs and Stock Jumps 23% in a Week β Can a New Finance Chief Revive a Sub-$2 Stock?
Shares of Veraxa Biotech AG shifted sharply upward as the Swiss clinical-stage biotech installed Raju Willener as its new Chief Financial Officer, effective...
π’ Veraxa Biotech is trading 8.5% up today after immediate appointment of Raju Willener as CFO
Veraxa Biotech is trading 8.5% up at $1.66 after announcing Raju Willenerβs immediate CFO appointment on September 4, 2026. - Willener brings more than 30...
π’ Veraxa Biotech is trading 12.3% up today as XBI gains 2.75%
Veraxa Biotech is trading at $1.55, up 12.32%, amid stronger biotech sector sentiment rather than a confirmed company-specific catalyst. - XBI is up 2.75%,...
π’ Veraxa Biotech is trading 5.4% up today amid patent-related enthusiasm
Veraxa Biotech is trading at $1.46, up +5.43% on September 3, 2026, amid patent-related enthusiasm and improving biotechnology sentiment. - The biotech sector...
π’ Veraxa Biotech is trading 14.27% up today β isolated rebound without a clear catalyst
Veraxa Biotech is trading 14.27% up now at $1.54, rebounding after several consecutive declines. - Shares fell from $1.95 on August 21, 2026, to $1.35 on...
π’ Veraxa Biotech is trading 8.89% up today after several consecutive declines
Veraxa Biotech is trading 8.89% up at $1.47, following several consecutive declines. - Closing price fell from $1.95 to $1.35 between August 21β31. - No clear...
π΄ Veraxa Biotech is trading 5.56% down today β no company-specific catalyst identified
Veraxa Biotech is trading 5.56% down now at $1.36 after extending declines from its August 27, 2026 close of $1.44; no credible company-specific announcement...